Latest FdaApproval News and Updates : FdaApproval updates, FdaApproval News , FdaApproval around the world

Nishadil

Washington | 23°C (overcast clouds)

FDA Approves AstraZeneca’s New Breast‑Cancer Therapy Amid Access Hurdles

Top story

FDA Approves AstraZeneca’s New Breast‑Cancer Therapy Amid Access Hurdles

In focus

Latest feed

When a Breakthrough Pancreatic Cancer Drug Hits the Market, Insurance Still Plays Catch‑up

Endometriosis: Why It Can Hide for Years and How New Tests Might Shine a Light

AstraZeneca’s Breast Cancer Pill Wins FDA Nod

A New Chapter for Juul? FDA Grants Permission for Age-Gated Vaping Device

Latest headlines

Teva's Strategic Leap: A Proposed Neuroscience Acquisition Paving the Way for Growth

Teva's Strategic Leap: A Proposed Neuroscience Acquisition Paving the Way for Growth

A Beacon of Hope: Cytokinetics' Myqorzo Delivers Promising Results for Overlooked Heart Condition

A Beacon of Hope: Cytokinetics' Myqorzo Delivers Promising Results for Overlooked Heart Condition

Myqorzo Shines: Cytokinetics' Aficamten Delivers Hope for Non-Obstructive HCM Patients

Myqorzo Shines: Cytokinetics' Aficamten Delivers Hope for Non-Obstructive HCM Patients

EyePoint's Rollercoaster Week: A Glimmer of Hope Amidst Trial Setbacks and Downgrades

EyePoint's Rollercoaster Week: A Glimmer of Hope Amidst Trial Setbacks and Downgrades

White House Order Seeks to Overhaul Childhood Vaccine Schedule, Igniting Fierce Debate

White House Order Seeks to Overhaul Childhood Vaccine Schedule, Igniting Fierce Debate

FDA Greenlights Zenbexus: A New Era for Multiple Myeloma Treatment

FDA Greenlights Zenbexus: A New Era for Multiple Myeloma Treatment

A New Dawn for Multiple Myeloma Patients: FDA Approves Bristol-Myers Squibb's Zenbexus

A New Dawn for Multiple Myeloma Patients: FDA Approves Bristol-Myers Squibb's Zenbexus

A New Horizon in Flu Protection: FDA Gives Green Light to Moderna's mRNA Vaccine

A New Horizon in Flu Protection: FDA Gives Green Light to Moderna's mRNA Vaccine

A New Era in Pain Relief? FDA Approves First-Ever OTC Tylenol & Naproxen Combo

A New Era in Pain Relief? FDA Approves First-Ever OTC Tylenol & Naproxen Combo

Why Korean Sunscreens Outshine U.S. Options: The Case for Bemotrizinol

Why Korean Sunscreens Outshine U.S. Options: The Case for Bemotrizinol

Barriers May Keep Merck’s New Cholesterol Pill From Success

Barriers May Keep Merck’s New Cholesterol Pill From Success

Sun Protection Gets a Boost: Meet the New Ingredient Changing Sunscreen

Sun Protection Gets a Boost: Meet the New Ingredient Changing Sunscreen

A Game Changer for Cholesterol? FDA Greenlights New Daily Pill Lipfendra

A Game Changer for Cholesterol? FDA Greenlights New Daily Pill Lipfendra

FDA Greenlights First Oral PCSK9 Inhibitor – Lipfendra

FDA Greenlights First Oral PCSK9 Inhibitor – Lipfendra

A Pill, Not a Shot: FDA Clears Merck’s First Oral PCSK9 Inhibitor

A Pill, Not a Shot: FDA Clears Merck’s First Oral PCSK9 Inhibitor

From Tragedy to Triumph: How Kiran Mazumdar‑Shaw Turned Personal Loss into a Global Biosimilar Breakthrough

From Tragedy to Triumph: How Kiran Mazumdar‑Shaw Turned Personal Loss into a Global Biosimilar Breakthrough

How a Personal Tragedy Drove Kiran Mazumdar‑Shaw to Pioneer Cancer Biosimilars at Biocon

How a Personal Tragedy Drove Kiran Mazumdar‑Shaw to Pioneer Cancer Biosimilars at Biocon

Stoke Therapeutics’ Dravet‑Syndrome Gene Therapy Nears the Finish Line

Stoke Therapeutics’ Dravet‑Syndrome Gene Therapy Nears the Finish Line

A Game-Changer in Heart Health: FDA Approves First-Ever Oral Pill to Tackle Stubborn Cholesterol

A Game-Changer in Heart Health: FDA Approves First-Ever Oral Pill to Tackle Stubborn Cholesterol

A New Dawn for Heart Health: FDA Greenlights Game-Changing Oral Cholesterol Pill

A New Dawn for Heart Health: FDA Greenlights Game-Changing Oral Cholesterol Pill

A Betrayal of Trust: The Alarming Tale of Aduhelm's Flawed Approval

A Betrayal of Trust: The Alarming Tale of Aduhelm's Flawed Approval

Viridian Therapeutics’ LUMVOA Gets FDA Nod, Poised for Market Debut

Viridian Therapeutics’ LUMVOA Gets FDA Nod, Poised for Market Debut

A Game Changer? Wockhardt's Zaynich Secures Landmark US FDA Nod for Stubborn UTIs

A Game Changer? Wockhardt's Zaynich Secures Landmark US FDA Nod for Stubborn UTIs

Boehringer Ingelheim’s Survodutide Shows Promise in Late‑Stage Obesity Trials

Boehringer Ingelheim’s Survodutide Shows Promise in Late‑Stage Obesity Trials

Dexcom’s New G7 CGM Shows Real‑World Benefits for Type 2 Diabetes

Dexcom’s New G7 CGM Shows Real‑World Benefits for Type 2 Diabetes

AkeSO’s Lung‑Cancer Drug Shows a Survival Edge Over the Current Standard

AkeSO’s Lung‑Cancer Drug Shows a Survival Edge Over the Current Standard

Mobia Medical's Rocky Start: Navigating the Treacherous Waters of Stroke Treatment

Mobia Medical's Rocky Start: Navigating the Treacherous Waters of Stroke Treatment

Mifepristone and the Courts: Decoding the Abortion Pill's Legal Rollercoaster

Mifepristone and the Courts: Decoding the Abortion Pill's Legal Rollercoaster

The Unfolding Legal Battle Over Mifepristone: A Closer Look at America's Most Common Abortion Pill

The Unfolding Legal Battle Over Mifepristone: A Closer Look at America's Most Common Abortion Pill

A New Era for Hearing: Gene Therapy Approved for Inherited Deafness

A New Era for Hearing: Gene Therapy Approved for Inherited Deafness

UCLA Shines as FDA Approves Groundbreaking Gene Therapy for Children

UCLA Shines as FDA Approves Groundbreaking Gene Therapy for Children

A New Dawn for Weight Loss? FDA Greenlights Game-Changing Oral GLP-1 Pill!

A New Dawn for Weight Loss? FDA Greenlights Game-Changing Oral GLP-1 Pill!

A New Chapter in Lupus Nephritis Care: Aurinia's Breakthrough

A New Chapter in Lupus Nephritis Care: Aurinia's Breakthrough

A New Dawn for Fragile Lives: Abeona Therapeutics' Zevaskyn Revenue Signals a Profound Shift

A New Dawn for Fragile Lives: Abeona Therapeutics' Zevaskyn Revenue Signals a Profound Shift

Sarepta's Shares Climb as Critical Safety Study for Elevidys Gene Therapy Kicks Off

Sarepta's Shares Climb as Critical Safety Study for Elevidys Gene Therapy Kicks Off

ImmunityBio's Stock Plunge: Can Dr. Soon-Shiong's Cancer Science Convince Skeptical Investors?

ImmunityBio's Stock Plunge: Can Dr. Soon-Shiong's Cancer Science Convince Skeptical Investors?

The Ozempic War is Over: What the Novo Nordisk and Hims & Hers Settlement Means for Your Access to GLP-1s

The Ozempic War is Over: What the Novo Nordisk and Hims & Hers Settlement Means for Your Access to GLP-1s

A New Chapter for Psoriatic Arthritis: Bristol Myers Squibb's Sotyktu Wins Key FDA Approval

A New Chapter for Psoriatic Arthritis: Bristol Myers Squibb's Sotyktu Wins Key FDA Approval

Load more